The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...
Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...
(RTTNews) - Roche (RHHBY) said that the U.S. Food and Drug Administration has granted Emergency Use Authorization for its cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test, an automated ...
Hosted on MSN
WHO prequalifies first rapid antigen tests for COVID-19, strengthening global diagnostic preparedness
More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic, the virus continues to circulate globally. While current data suggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results